TrialClinical lymphoma, myeloma & leukemia2017

Practical Measures of Clinical Benefit With Ruxolitinib Therapy: An Exploratory Analysis of COMFORT-I.

Carole B Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.